Epstein–Barr virus-encoded latent membrane protein 1 is expressed in NPC and increases the maturation and activation of SREBP-1 to induce de novo lipid synthesis in the tumor growth and metastasis, which can be inhibited by two inhibitors, luteolin and fatostatin (131). This evidence concerns the gene SREBF1 and nasopharyngeal carcinoma.